BioWorld-International-2002-05-22
European Parliament Endorses Part Of Biotech Spending Plan
Ark Delays Initial Public Offering Due To Unfavorable Conditions
LONDON - Ark Therapeutics Group plc postponed its initial public offering on the London Stock Market, blaming "unusually adverse market conditions." (BioWorld International)

